Telesis Bio, Inc. (TBIO)
USD 0.29
(-1.72%)
USD 0.29
(-1.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 63.48 Million USD | -22.68% |
| 2022 | 62.08 Million USD | 56.48% |
| 2021 | 39.67 Million USD | 98.5% |
| 2020 | 19.98 Million USD | 591.08% |
| 2019 | 2.89 Million USD | -96.41% |
| 2018 | 80.63 Million USD | 31.46% |
| 2017 | 61.33 Million USD | 128.84% |
| 2016 | 26.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.79 Million USD | -13.7% |
| 2024 Q2 | 8.86 Million USD | 21.61% |
| 2023 Q3 | 13.11 Million USD | -3.96% |
| 2023 Q2 | 13.65 Million USD | -5.68% |
| 2023 Q4 | 10.18 Million USD | -22.34% |
| 2023 FY | 47.99 Million USD | -22.68% |
| 2023 Q1 | 14.48 Million USD | 1.06% |
| 2022 FY | 62.08 Million USD | 56.48% |
| 2022 Q1 | 15.64 Million USD | 20.51% |
| 2022 Q4 | 14.33 Million USD | -3.89% |
| 2022 Q3 | 14.91 Million USD | -13.31% |
| 2022 Q2 | 17.19 Million USD | 9.96% |
| 2021 FY | 39.67 Million USD | 98.5% |
| 2021 Q1 | 7.56 Million USD | 24.26% |
| 2021 Q2 | 8.52 Million USD | 12.68% |
| 2021 Q4 | 12.97 Million USD | 22.41% |
| 2021 Q3 | 10.6 Million USD | 24.38% |
| 2020 Q1 | 4.4 Million USD | -86.38% |
| 2020 Q2 | 4.29 Million USD | -2.61% |
| 2020 Q3 | 5.19 Million USD | 21.03% |
| 2020 Q4 | 6.08 Million USD | 17.19% |
| 2020 FY | 19.98 Million USD | 591.08% |
| 2019 Q4 | 32.37 Million USD | 33.91% |
| 2019 FY | 2.89 Million USD | -96.41% |
| 2019 Q3 | 24.17 Million USD | -1.22% |
| 2019 Q2 | 24.47 Million USD | 2.08% |
| 2019 Q1 | 23.97 Million USD | 4.02% |
| 2018 Q1 | 17.48 Million USD | 0.44% |
| 2018 Q2 | 21.21 Million USD | 21.33% |
| 2018 Q3 | 18.89 Million USD | -10.94% |
| 2018 Q4 | 23.05 Million USD | 22.02% |
| 2018 FY | 80.63 Million USD | 31.46% |
| 2017 FY | 61.33 Million USD | 128.84% |
| 2017 Q1 | 12.59 Million USD | 0.0% |
| 2017 Q2 | 16.63 Million USD | 32.05% |
| 2017 Q3 | 14.7 Million USD | -11.59% |
| 2017 Q4 | 17.4 Million USD | 18.36% |
| 2016 FY | 26.8 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -465.654% |
| Cerus Corporation | 143.15 Million USD | 55.65% |
| OrthoPediatrics Corp. | 137.01 Million USD | 53.664% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -458.839% |
| Talis Biomedical Corporation | 67.18 Million USD | 5.503% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -154.506% |
| Inogen, Inc. | 236.08 Million USD | 73.108% |
| Spectral AI, Inc. | 20.86 Million USD | -204.299% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -13.379% |
| CVRx, Inc. | 76.14 Million USD | 16.618% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1699.577% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -408.359% |
| Orthofix Medical Inc. | 667.42 Million USD | 90.487% |
| Venus Concept Inc. | 80.47 Million USD | 21.108% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -12.215% |
| Bioventus Inc. | 409.91 Million USD | 84.512% |
| BrainsWay Ltd. | 28.01 Million USD | -126.601% |
| Envoy Medical, Inc. | 17.89 Million USD | -254.727% |
| electroCore, Inc. | 32.03 Million USD | -98.211% |
| IceCure Medical Ltd | 16.87 Million USD | -276.209% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -49.625% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -260.057% |
| MaxCyte, Inc. | 84.84 Million USD | 25.171% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -411.523% |
| Nexalin Technology, Inc. | 5.78 Million USD | -998.168% |
| PAVmed Inc | 64.82 Million USD | 2.064% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -24.298% |
| RxSight, Inc. | 103.85 Million USD | 38.865% |
| Sight Sciences, Inc. | 126.44 Million USD | 49.791% |
| SI-BONE, Inc. | 156.35 Million USD | 59.393% |
| TELA Bio, Inc. | 84.18 Million USD | 24.586% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 9.374% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 68.781% |
| LivaNova PLC | 843.54 Million USD | 92.474% |
| 908 Devices Inc. | 68.08 Million USD | 6.744% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 86.872% |
| Nemaura Medical Inc. | 7.13 Million USD | -789.351% |
| NeuroPace, Inc. | 75.29 Million USD | 15.681% |
| LENSAR, Inc. | 33.33 Million USD | -90.452% |
| Apyx Medical Corporation | 51.01 Million USD | -24.444% |
| Cutera, Inc. | 197.72 Million USD | 67.89% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -156.2% |
| BioSig Technologies, Inc. | 28.53 Million USD | -122.534% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 66.842% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -76.065% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 92.409% |
| Axonics, Inc. | 270.2 Million USD | 76.503% |
| Outset Medical, Inc. | 198.77 Million USD | 68.059% |
| IRIDEX Corporation | 31.81 Million USD | -99.563% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 64.771% |
| IRadimed Corporation | 30.12 Million USD | -110.767% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -644.128% |
| INVO Bioscience, Inc. | 7.85 Million USD | -708.438% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 35.513% |
| Varex Imaging Corporation | 224.8 Million USD | 71.758% |
| Quipt Home Medical Corp. | 148.66 Million USD | 57.294% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -441.576% |
| Pulmonx Corporation | 112.68 Million USD | 43.659% |
| Dynatronics Corporation | 9.9 Million USD | -540.784% |
| Modular Medical, Inc. | 17.52 Million USD | -262.194% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -214.504% |
| Semler Scientific, Inc. | 38.94 Million USD | -63.026% |
| InMode Ltd. | 215.68 Million USD | 70.563% |
| Bruker Corporation | 1.07 Billion USD | 94.102% |
| Cytosorbents Corporation | 48.33 Million USD | -31.347% |
| DexCom, Inc. | 1.69 Billion USD | 96.246% |
| Align Technology, Inc. | 2.07 Billion USD | 96.943% |
| Viveve Medical, Inc. | 22.17 Million USD | -186.335% |
| ZimVie Inc. | 275.12 Million USD | 76.924% |
| Movano Inc. | 29.69 Million USD | -113.84% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 53.749% |
| Nexalin Technology, Inc. | 5.78 Million USD | -998.168% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1699.577% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 89.435% |
| Profound Medical Corp. | 33.6 Million USD | -88.938% |
| Insulet Corporation | 939.9 Million USD | 93.245% |
| enVVeno Medical Corporation | 25.23 Million USD | -151.561% |
| Surmodics, Inc. | 98.69 Million USD | 35.673% |
| iCAD, Inc. | 22.22 Million USD | -185.665% |
| Nuwellis, Inc. | 22.61 Million USD | -180.763% |
| Biotricity, Inc. | 17.18 Million USD | -269.454% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 85.761% |
| Aethlon Medical, Inc. | 12.27 Million USD | -417.116% |
| InspireMD, Inc. | 22.95 Million USD | -176.641% |
| PAVmed Inc. | 64.82 Million USD | 2.064% |
| BIOLASE, Inc. | 34.66 Million USD | -83.171% |
| Beyond Air, Inc. | 61.7 Million USD | -2.9% |
| FONAR Corporation | 28.6 Million USD | -121.953% |
| AxoGen, Inc. | 149.33 Million USD | 57.486% |
| Vivani Medical, Inc. | 26.96 Million USD | -135.45% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 64.149% |
| Inari Medical, Inc. | 448.59 Million USD | 85.847% |
| UFP Technologies, Inc. | 58.08 Million USD | -9.296% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1188.437% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -904.845% |
| Tenon Medical, Inc. | 16.96 Million USD | -274.169% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -758.772% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -43.957% |
| AdaptHealth Corp. | 1.07 Billion USD | 94.11% |
| Sintx Technologies, Inc. | 15.2 Million USD | -317.663% |
| NanoVibronix, Inc. | 4.97 Million USD | -1176.674% |
| Quanterix Corporation | 118.1 Million USD | 46.241% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -441.576% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -339.614% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 83.831% |
| TransMedics Group, Inc. | 182.82 Million USD | 65.272% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -126.221% |
| NeuroMetrix, Inc. | 11.09 Million USD | -472.028% |
| Hyperfine, Inc. | 52.87 Million USD | -20.081% |
| Establishment Labs Holdings Inc. | 172 Million USD | 63.088% |
| Biomerica, Inc. | 6.97 Million USD | -809.845% |
| Bone Biologics Corporation | 9.42 Million USD | -573.387% |
| AVITA Medical, Inc. | 80.77 Million USD | 21.404% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -515.728% |
| Silk Road Medical, Inc | 186.35 Million USD | 65.932% |